Name
The High Toll of High-Cost Conditions
Date & Time
Thursday, June 10, 2021, 10:20 AM - 10:44 AM
Description

People with cancer, cardiovascular disease and diabetes – historically high-cost conditions for employers – have been at high risk for complications for COVID-19. Can new treatments and approaches enable us to more effectively address these illnesses? How much will this cost employers?

Thomas C. Squires, Esq. James Mansi Sarah Moseley, PhD Mark Godwin, PharmD Annette Powers, PharmD